Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

Author:

Wirth Lori J.1ORCID,Sherman Eric1,Robinson Bruce1,Solomon Benjamin1,Kang Hyunseok1ORCID,Lorch Jochen1,Worden Francis1,Brose Marcia1,Patel Jyoti1,Leboulleux Sophie1,Godbert Yann1,Barlesi Fabrice1,Morris John C.1,Owonikoko Taofeek K.1,Tan Daniel S.W.1,Gautschi Oliver1,Weiss Jared1,de la Fouchardière Christelle1,Burkard Mark E.1,Laskin Janessa1,Taylor Matthew H.1,Kroiss Matthias1ORCID,Medioni Jacques1,Goldman Jonathan W.1,Bauer Todd M.1,Levy Benjamin1,Zhu Viola W.1,Lakhani Nehal1,Moreno Victor1,Ebata Kevin1,Nguyen Michele1,Heirich Dana1,Zhu Edward Y.1,Huang Xin1,Yang Luxi1,Kherani Jennifer1,Rothenberg S. Michael1,Drilon Alexander1,Subbiah Vivek1ORCID,Shah Manisha H.1,Cabanillas Maria E.1ORCID

Affiliation:

1. From Massachusetts General Hospital (L.J.W.) and Dana–Farber Cancer Institute (J. Lorch), Boston; Memorial Sloan Kettering Cancer Center, New York (E.S., A.D.); Royal North Shore Hospital, St. Leonards, NSW (B.R.), and Peter MacCallum Cancer Institute, Melbourne, VIC (B.S.) — both in Australia; University of California, San Francisco–Helen Diller Family Comprehensive Cancer Center, San Francisco (H.K.), David Geffen School of Medicine at UCLA, Los Angeles (J.W.G.), and Chao Family Comprehensive Cancer...

Funder

Loxo Oncology

Publisher

Massachusetts Medical Society

Subject

General Medicine

Cited by 448 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3